Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen

Journal of Clinical Investigation

Volumn 91, Issue 1, 1993, Pages 308-318

  Stamler, Jonathan S ^a   Osborne, John A ^a   Jaraki, Omar ^a   Rabbani, Leroy E ^a   Mullins, Mark ^b   Singel, David ^b   Loscalzo, Joseph ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD UNIVERSITY   (United States)

Author keywords

Endothelial cells; Nitric oxide; Thiols

Indexed keywords

AMINO ACID DERIVATIVE; CYCLIC GMP; ENDOTHELIUM DERIVED RELAXING FACTOR; HOMOCYSTEINE; HOMOCYSTEINE THIOLACTONE; HYDROGEN PEROXIDE; NITRIC OXIDE; NITROSO DERIVATIVE; S NITROSOHOMOCYSTEINE; THIOL GROUP; UNCLASSIFIED DRUG;

AEROBIC METABOLISM; ANIMAL CELL; ARTICLE; CATTLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; ENDOTHELIUM CELL; NITROSATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOGENICITY; VASODILATATION;

ADENOSINE DIPHOSPHATE; ANIMAL; AORTA; BLOOD PLATELETS; CATTLE; CELLS, CULTURED; CHEMILUMINESCENCE; COLLAGEN; COPPER; CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; HOMOCYSTEINE; HOMOCYSTINE; HUMAN; HYDROGEN PEROXIDE; IN VITRO; IRON; KINETICS; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, CARDIOVASCULAR; NITRIC OXIDE; NITROGEN OXIDES; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027531427     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI116187     Document Type: Article

References (68)

1. Clarke, R., L. Daly, K. Robinson, E. Naughten, S. Cahalane, B. Fowler, and I. Graham. 1991. Hyperhomocysteinemia: an independent risk factor for vascular disease. N. Engl. J. Med. 324:1149-1155.
2. Malinow, M. R. 1990. Hyperhomocyst(e)inemia: a common and easily reversible risk factor for occlusive atherosclerosis. Circulation. 81:2004-2006.
3. Malinow, M. R., G. Sexton, M. Averbuch, M. Grossman, D. Wilson, and B. Upson. 1990. Homocyst(e)inemia in daily practice: levels in coronary artery disease. Coronary Artery Disease. 1:215-220.
4. Perry, T. L. 1967. In Amino Acid Metabolism and Genetic Variation. W. L. Nyhan, editor. McGraw-Hill Inc., New York.
5. Perry, T. L., S. Hansen, L. MacDougall, P. D. Warrington. 1967. Sulfurcontaining amino acids in the plasma and urine of homocystinurics. Clin. Chim. Acta. 15:409-420.
6. Kang, S.-S., P. W. K. Wong, H. Y. Cook, M. Norusis, and J. V. Messer. 1986. Protein-bound homocyst(e)ine: a possible risk factor for coronary artery disease. J. Clin. Invest. 77:1482-1486.
7. Refsum, H., S. Helland, and P. M. Ueland. 1985. Radioenzymicdetermination of homocysteine in plasma and urine. Clin. Chem. 31:624-628.
8. Spindel, E., and K. S. McCully. 1974. Conversion of methionine to homocysteine thiolactone in liver. Biochim. Biophys. Acta. 343:687-691.
9. McCully, K. S. 1971. Homocysteine metabolism in scurvy, growth and arteriosclerosis. Nature (Lond.). 231:391-392.
10. James, T. N. 1990. The spectrum of diseases of the small coronary arteries and their physiologic consequences. J. Am. Coll. Cardiol. 15:763-774.
11. Harker, L. A., S. J. Slichter, C. R. Scott, and R. Ross. 1974. Homocystinen mia: vascular injury and arterial thrombosis. N. Engl. J. Med. 291:537-543.
12. Harker, L. A., R. Ross, S. J. Slichter, and C. R. Scott. 1976. Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis. J. Clin. Invest. 58:731-741.
13. McDonald, L., C. Bray, C. Field, F. Love, and B. Davies. 1964. Homocystinuria, thrombosis, and the blood-platelets. Lancet. i:745-746.
14. Graeber, J. E., J. H. Slott, R. E. Ulane, J. D. Schulman, and M. J. Stuart. 1982. Effect of homocysteine and homocystine on platelet and vascular arachidonic acid metabolism. Pediatr. Res. 16:490-493.
15. McCully, K. S., and A. C. A. Carvalho. 1987. Homocysteine thiolactone, N-homocysteine thiolactonyl retinamide, and platelet aggregation. Res. Commun. Chem. Pathol. Pharmacol. 56:349-360.
16. Davis, J. W., L. D. Flournoy, and P. E. Phillips. 1975. Amino acids and collagen-induced platelet aggregation. Am. J. Dis. Child. 129:1020-1021.
17. Zweifler, A. J., and R. J. Allen. 1971. An intrinsic blood platelet abnormality in a homocystinuric boy corrected by pyridoxine administration. Thromb. Dialh. Haemorrh. XXVI:15-21.
18. Hilden, M., N. J. Brandt, I. M. Nilsson, and F. Schonheyder. 1974. Investigations of coagulation and fibrinolysis in homocystinuria. Acta Med. Scand. 195:533-535.
19. Thomas, G., V. A. Skrinska, and F. V. Lucas. 1986. The influence of glutathione and other thiols on human platelet aggregation. Thromb. Res. 44:859-866.
20. Stamler, J., M. Cunningham, and J. Loscalzo. 1988. Reduced thiols and the effect of intravenous nitroglycerin on platelet aggregation. Am. J. Cardiol. 62:377-380.
21. Wall, R. T., J. M. Harlan, L. A. Harker, and G. E. Striker. 1980. Homocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury. Thromb. Res. 18:113-121.
22. Starkebaum, G., and J. M. Harlan. 1986. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J. Clin. Invest. 77:1370-1376.
23. de Groot, P. G., C. Willems, G. H. J. Boers, M. D. Gonsalves, W. G. van Aken, and J. A. van Mourik. 1983. Endothelial cell dysfunction in homocystinuria. Eur. J. Clin. Invest. 13:405-410.
24. McCully, K. S., and B. D. Ragsdale. 1970. Production of arteriosclerosis by homocysteinemia. Am. J. Pathol. 61:1-8.
25. McCully, K. S., and R. B. Wilson. 1975. Homocysteine theory of arteriosclerosis. Atherosclerosis. 22:215-227.
26. Palmer, R. M. J., A. G. Ferrige, and S. Moncada. 1987. Nitric oxide k release accounts for the biological activity of endothelium-derived relaxing factor. Nature (Lond.). 327:524-526.
27. Ignarro, L. J., G. M. Buga, K. S. Wood, R. E. Byrns, and G. Chaudhuri. 1987. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. USA. 84:9265-9269.
28. Myers, P. R., R. L. Minor, Jr., R. Guerra, Jr., H. Bates, and D. G. Harrison. 1990. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide. Nature (Lond.). 345:161-163.
29. Wei, E. P., and H. Kontos. 1990. Hydrogen peroxide and endothelium-dependent arteriolar dilation. Implications for the identification of endothelium-derived relaxing factor generated by acetycholine. Hypertension (Dallas). 16:162-169.
30. Oae, S., and K. Shinhama. 1983. Organic thionitrites and related substances. A review. Org. Prep. Proc. 15:165-169.
31. Stamler, J. S., D. I. Simon, J. A. Osborne, M. E. Mullins, O. Jaraki, T. Michel, D. J. Singel, and J. Loscalzo. 1992. S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc. Natl. Acad. Sci. USA. 89:444-448.
32. Schwartz, S. W. 1978. Selection and characterization of bovine aortic endothelial cells. In Vitro (Rockville). 14:966-980.
33. Davies, P. F., G. A. Truskey, H. B. Warren, S. E. O'Connor, and B. H. Eisenhaure. 1985. Metabolic cooperation between vascular endothelial cells and smooth muscle cells in co-culture: changes in low density lipoprotein metabolism. J. Cell. Biol. 101:871-879.
34. Stamler, J. S., M. E. Mendelsohn, P. Amarante, D. Smick, N. Andon, P. F. Davies, J. P. Cooke, and J. Loscalzo. 1989. N-acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor. Circ. Res. 65:789-795.
35. Cooke, J. P., J. S. Stamler, N. Andon, P. F. Davies, and J. Loscalzo. 1989. Flow stimulates endothelial cells to release a nitrovasodilator that is potentiated by reduced thiol. Am. J Physiol. 28:H804-H812.
36. Phillips, P. G., and M.-F. Tsan. 1988. Direct staining and visualization of endothelial monolayers cultured on synthetic polycarbonate filters. J. Histochem. Cytochem. 36:551-554.
37. Hawiger, J., S. Parkinson, and S. Timmons. 1980. Prostacyclin inhibits mobilization of fibrinogen-binding sites on human ADP- and thrombin-treated platelets. Nature (Lond.). 2831:195-198.
38. Born, G. V., and M. J. Cross. 1963. The aggregation of blood platelets. J. Physiol. (Lond.) 168:178-195.
39. Osborne, J. A., P. H. Lento, M. R. Siegfried, G. L. Stahl, B. Fusman, and A. M. Lefer. 1989. Cardiovascular effects of acute hypercholeslerolemia in rabbits. Reversal with lovastatin treatment. J. Clin. Invest. 83:465-473.
40. Sedlak, J., and R. H. Lindsay. 1968. Estimation of total protein-bound and nonprotein-bound sulfhydryl groups in tissue with Ellman's reagent. Anal. Biochem. 25:195-205.
41. 2 release from human granulocytes during phagocytosis. I. Documentation, quantitation, and some regulating factors. J. Clin. Invest. 53:945-955.
42. Saville, B. 1958. A scheme for the colorimetric determination of microgram amounts of thiols. Analyst. 83:670-672.
43. 15N NMR studies. J. Chem. Soc. Perkin Trans. I. 2261-2264.
44. Stamler, J. S., O. Jaraki, J. A. Osborne, D. I. Simon, J. Keaney, J. Vita, D. Singel, C. R. Valeri, and J. Loscalzo. 1992. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc. Natl. Acad. Sci. USA. 89:7674-7677.
45. Stamler, J. S., and J. Loscalzo. 1992. Capillary zone electrophoretic detection of biologic thiols and their S-nitrosated derivatives. Anal. Chem. 64:779-785.
46. Kowaluk, E. A., and H.-L. Fung. 1990. Spontaneous liberation of nitric oxide cannot account for in vitro vascular relaxation by S-nitrosothiols. J. Pharmacol. Exp. Ther. 256:1256-1264.
47. Aldred, S. E., and D. L. H. Williams. 1987. Kinetics and mechanism of the nitrosation of alcohols, carbohydrates and a thiol. J. Chem. Soc. Perkin Trans. II. 777-782.
48. Byler, D. M., D. K. Grosser, and H. Susi. 1983. Spectroscopic estimation of the extent of S-nitrosothiol formation by nitrite action on sulfhydryl groups. J. Agric. Food. Chem. 31:523-527.
49. Riegel, B., and V. Du Vigneaud. 1935. The isolation of homocysteine and its conversion to a thiolactone. J. Biol. Chem. 112:149-154.
50. Ignarro, L. J., J. C. Edwards, D. Y. Gruetter, B. K. Barry, and C. A. Gruetter. 1980. Possible involvement of S-nitrosothiols in the activation of guantlate cyclase by nitroso-compounds. FEBS (Fed. Eur. Biochem. Soc.) Lett. 110:275-278.
51. Zucker, M. B., and N. C. Masiello. 1984. Platelet aggregation caused by dithiothreitol. Thromb. Haemostasis. 51:119-124.
52. Hofman, J., W. Losche, B. Hofman, P. Arese, A. Bosia, G. Pescarmona, and U. Till. 1983. Effects of compounds causing reversible pertubation of the cellular thiol disulfide status on the aggregation of human platelets. Biomed. Biochim. Acta. 42:479-487.
53. Ignarro, L. J. 1989. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ. Res 65:1-21.
54. Schimke, R. N., V. A. McKusick, T. Hwang, and A. D. Pollack. 1965. Homocystinuria. Studies of 20 families with 38 affected members. JAMA (J. Am. Med. Assoc.). 193:711.
55. 111Indium-labeled platelets in patients with homocystinuria. N. Engl. J. Med. 307:781-786.
56. Uhleman, E. R., J. H. TenPas, A. W. Lucky, J. D. Schulman, S. H. Mudd, and N. R. Schulman. 1982. Platelet survival and morphology in homocystinuria due to cystathionine synthase deficiency. N. Engl. J. Med. 307:781-786.
57. Rodgers, G. M., and M. T. Conn. 1990. Homocysteine, an atherogenic stimulus reduces protein C activation by arterial and venous endothelial cells. Blood. 75:895-901.
58. Jocelyn, P. C. 1972. In Biochemistry of the SH Group. Academic Press Ltd., London, pp. 39 and 253.
59. Randon, J., T. Lecompte, M. Chignard, W. Siess, G. Marias, F. Dray, and B. B. Vargaftig. 1981. Dissociation of platelet activation from transmethylation of their membrane phospholipids. Nature (Lond.). 293:660-662.
60. Akbar, H., and K. Romstedt. 1984. 3-Deazoadenosine and L-homocysteine inhibit human platelet activation induced by arachidonic acid, U46619 and phospholipase C. Thromb. Res. 36:369-376.
61. Eger, W. 1957. Die Bedeutung der sulfhydryl-amino and carboxyl-gruppen Kurzkettiger Kohlenstoffverbindungen fur ihre nekrotrope Leberschitzwitkung. Arzneim. Forsch. 7:601-606.
62. Rodgers, G. M., and W. H. Kane. 1986. Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator. J. Clin. Invest. 77:1909-1916.
63. Gaggi, R., and A. M. Gianni. 1973. The role of homocysteine in the pathogenesis of atherosclerosis. Arzneim. Forsch. 2:287-297.
64. Mollace, V., D. Salvenini, W. C. Sessa, and J. R. Vane. 1991. Inhibition of human platelet aggregation by endothelium-derived relaxing factor, sodium nitroprusside or iloprost is potentiated by captopril and reduced thiols. J. Pharmacol. Exp. Ther. 258:820-823.
65. Nishiuch, Y., M. Sasaki, M. Nakayasu, and A. Oikawa. 1976. Cytotoxicity of cysteine in culture media. In Vitro. 12:635-638.
66. Parfhasarathy, S. 1987. Oxidation of low-density lipoprotein by thiol compounds leads to its recognition by the acetyl LDL receptor. Biochim. Biophys. Acta. 917:337-340.
67. Heinecke, J. W., H. Rosen, L. A. Suzuki, and A. Chait. 1987. The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells. J. Biol. Chem. 262:10098-10103.
68. Feelisch, M., and E. A. Novack. 1987. Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase. Eur. J. Pharm. 139:19-30.